DDX3 was reported as an oncogene in Ewing sarcoma, breast cancer [15, 16] prostate cancer [14], gallbladder carcinoma as well as pancreatic ductal adenocarcinoma [17], while being tumor suppressive in melanoma [18]. This evidence concerns the gene DDX3X and prostate cancer.